BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.580
-0.010 (-0.63%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BioVie Market Cap
BioVie has a market cap or net worth of $11.91 million as of April 28, 2026. Its market cap has decreased by -17.26% in one year.
Market Cap
11.91M
Enterprise Value
-8.31M
1-Year Change
-17.26%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.91M, a decrease of -77.09%. That is a compound annual growth rate of -23.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.90M | 36.78% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 12.43M |
| Traws Pharma | 11.78M |
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.59M |
| Reviva Pharmaceuticals Holdings | 11.53M |
| BioLineRx | 11.36M |
| CytoMed Therapeutics | 11.25M |
| Lunai Bioworks | 11.25M |